Table 2

Overall TE incidence (n=500)

VariableNo. of patients (%)
All TE70 (14.0)
Types of TE (n=70)
 VTE alone49 (70.0)
 ATE alone9 (12.9)
 PE alone6 (8.6)
 VTE+PE3 (4.3)
 ATE+PE1 (1.4)
 VTE+ATE1 (1.4)
 Appendage1 (1.4)
Symptomatic or incidental TE
 Symptomatic5 (7.1)
 Incidental65 (92.9)
Treatment for TE
 No treatment40 (57.1)
 Warfarin alone12 (17.1)
 Edoxaban alone5 (7.1)
 UFH3 (4.3)
 CV port removal2 (2.9)
 IVC filter+Warfarin+UFH2 (2.9)
 Danaparoid sodium1 (1.4)
 Ozagrel sodium1 (1.4)
 Already receiving oral anticoagulants4 (5.7)
  • ATE, arterial thromboembolism; CV, central venous; IVC, inferior vena cava; PE, pulmonary embolism; TE, thromboembolism; UFH, unfractionated heparin; VTE, venous thromboembolism.